Sign in
4

Changes in Ownership

Vera Therapeutics, Inc. Filed Acc 0001209191-22-044412

Chief Development Officer sold 988 shares at $16.81 ($16,608)

From the SEC's structured data for this filing

Trades in this filing

Curley Joanne · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-08-03 Sale : show line 1 in the form −988 $16.81 $16,608 17,285 D
Open-market sales · 988 sh · avg $16.81 · $16,608
Loading xslF345X03/doc4.xml…